Published in Ophthalmology on July 01, 1992
Transforming growth factor-beta: recent progress and new challenges. J Cell Biol (1992) 3.18
Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med (1994) 2.86
Prophylactic scleral buckle for prevention of retinal detachment following vitrectomy for macular hole. Br J Ophthalmol (1999) 1.57
Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol (2003) 1.10
Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes. Br J Ophthalmol (1995) 1.09
Phacovitrectomy without prone posture for full thickness macular holes. Br J Ophthalmol (2001) 1.07
A major advance in the use of growth factors to enhance wound healing. J Clin Invest (1993) 1.03
Late reopening of successfully treated macular holes. Br J Ophthalmol (1997) 1.00
Idiopathic full thickness macular hole: natural history and pathogenesis. Br J Ophthalmol (2001) 1.00
Surgical management of macular holes: results using gas tamponade alone, or in combination with autologous platelet concentrate, or transforming growth factor beta 2. Br J Ophthalmol (1997) 0.96
Stage III macular hole surgery. Br J Ophthalmol (1993) 0.95
Fundus autofluorescence in patients with macular holes imaged with a laser scanning ophthalmoscope. Br J Ophthalmol (1998) 0.94
Macular hole and myopic refraction. Br J Ophthalmol (2002) 0.91
Predicting visual outcome after macular hole surgery using scanning laser ophthalmoscope microperimetry. Br J Ophthalmol (2001) 0.86
Long term result of silicone oil versus gas tamponade in the treatment of traumatic macular holes. Clin Ophthalmol (2012) 0.82
Objective morphological assessment of macular hole surgery by scanning laser tomography. Br J Ophthalmol (1997) 0.82
Efficacy of autologous platelets in macular hole surgery. Clin Ophthalmol (2013) 0.80
[Macular hole. Survey and relevant surgical concepts]. Ophthalmologe (2005) 0.79
Macular holes. Br J Ophthalmol (1995) 0.78
Macular holes: migratory gaps and vitreous as obstacles to glial closure. Graefes Arch Clin Exp Ophthalmol (1997) 0.78
Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies. Biochem J (1996) 0.75
Laser photocoagulation as adjuvant therapy to surgery for large macular holes. Korean J Ophthalmol (2006) 0.75
Management of Stage IV Macular Holes: When Standard Surgery Fails. Case Rep Ophthalmol (2012) 0.75
Surgical closure of macular hole using an absorbable macular plug. Int Ophthalmol (1997) 0.75
Pars Plana Vitrectomy with Internal Limiting Membrane Peeling in Traumatic Macular Hole: 14% Perfluoropropane (C3F8) versus Silicone Oil Tamponade. J Ophthalmol (2017) 0.75
Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med (1999) 3.38
Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol (1981) 2.34
Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest (1989) 2.16
Penetrating ocular injuries. Types of injuries and visual results. Ophthalmology (1983) 2.15
Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol (1995) 2.03
Intraocular tamponade duration and success of macular hole surgery. Retina (1996) 1.91
Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol (1980) 1.87
The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes. Ophthalmology (1993) 1.82
Refractive changes after scleral buckling surgery. Arch Ophthalmol (1989) 1.81
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med (1997) 1.80
Vitrectomy for macular pucker. Ophthalmology (1984) 1.68
Vitreous surgery for macular pucker. Am J Ophthalmol (1981) 1.63
Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients. J Infect Dis (1999) 1.61
Full-thickness macular hole formation in eyes with a pre-existing complete posterior vitreous detachment. Ophthalmology (1995) 1.60
Prognostic factors in vitrectomy for epiretinal membranes of the macula. Ophthalmology (1986) 1.58
Vitreoretinal surgery through multifocal intraocular lenses compared with monofocal intraocular lenses in fluid-filled and air-filled rabbit eyes. Ophthalmology (2000) 1.52
Endophthalmitis due to Propionibacterium acnes sequestered between IOL optic and posterior capsule. Ophthalmic Surg (1989) 1.48
Vitrectomy for idiopathic epiretinal membranes causing macular pucker. Br J Ophthalmol (1988) 1.47
Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology (1987) 1.46
Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology (1989) 1.45
Idiopathic epiretinal membranes. Ultrastructural characteristics and clinicopathologic correlation. Ophthalmology (1989) 1.45
A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope. Am J Ophthalmol (2004) 1.44
Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants. Ophthalmology (1986) 1.44
Nuclear sclerotic cataract after vitrectomy for idiopathic epiretinal membranes causing macular pucker. Am J Ophthalmol (1991) 1.42
Nuclear sclerosis after vitrectomy for idiopathic epiretinal membranes. Am J Ophthalmol (1988) 1.41
Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A review. Retina (1990) 1.40
Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology (1997) 1.33
Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology (1984) 1.32
Silicone oil in the treatment of complicated retinal detachments. Ophthalmology (1987) 1.30
A sensitive and specific polymerase chain reaction-based assay for the diagnosis of cytomegalovirus retinitis. Am J Ophthalmol (1995) 1.28
Surgical vitrectomy for pseudophakic malignant glaucoma. Am J Ophthalmol (1986) 1.27
Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group. N Engl J Med (1997) 1.27
Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology (1983) 1.26
Vitrectomy for complications of diabetic retinopathy. Arch Ophthalmol (1978) 1.25
Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage. Arch Ophthalmol (1987) 1.24
Iatrogenic retinal breaks complicating pars plana vitrectomy. Ophthalmology (1990) 1.23
Pars plana vitrectomy in the management of endogenous Candida endophthalmitis. Am J Ophthalmol (1976) 1.23
Retinal detachment after extracapsular cataract extraction with posterior chamber intraocular lens. Ophthalmology (1987) 1.23
Vitrectomy for macular traction caused by incomplete vitreous separation. Arch Ophthalmol (1988) 1.22
Vitrectomy techniques in the management of selected penetrating ocular injuries. Ophthalmology (1978) 1.21
Multivariate analysis of prognostic factors in penetrating ocular injuries. Am J Ophthalmol (1984) 1.20
Retinal detachment in highly myopic eyes due to macular holes and epiretinal traction. Retina (1990) 1.17
A clinical and histopathologic study of epiretinal membranes affecting the macula and removed by vitreous surgery. Trans Am Ophthalmol Soc (1982) 1.16
The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol (1974) 1.16
Prognostic indicators of success and failure in vitrectomy for diabetic retinopathy. Ophthalmology (1986) 1.14
Vitrectomy for impending idiopathic macular holes. Am J Ophthalmol (1988) 1.14
Macular hole surgery in high myopia. Ophthalmology (2001) 1.13
Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol (1985) 1.13
Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol (1980) 1.12
Hospitalization requirements after vitreoretinal surgery. Arch Ophthalmol (1988) 1.12
Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology (1998) 1.11
Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol (1983) 1.10
Complications of vitreous surgery for diabetic retinopathy. I. Intraoperative complications. Ophthalmology (1983) 1.08
A polymerase chain reaction-based assay for diagnosing varicella-zoster virus retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1997) 1.08
Surgical management of epithelial ingrowth. Am J Ophthalmol (1978) 1.08
Indocyanine green angiography in multiple evanescent white-dot syndrome. Am J Ophthalmol (1994) 1.08
Presumed varicella zoster retinitis in immunocompromised patients. Retina (1987) 1.08
Treatment of acquired epithelial inclusion cyst of the conjunctiva using the YAG laser. Am J Ophthalmol (1984) 1.07
Intraocular reticulum cell sarcoma. Diagnosis by pars plana vitrectomy. Arch Ophthalmol (1975) 1.07
A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. J Infect Dis (1993) 1.07
Clinicopathologic study of idiopathic macular pucker in children and young adults. Retina (1992) 1.02
Scleral buckling methods for rhegmatogenous retinal detachment. Retina (1986) 1.02
Vitrectomy for progressive proliferative diabetic retinopathy. Arch Ophthalmol (1987) 1.02
The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol (1983) 1.01
Results of rhegmatogenous retinal detachment repair in cytomegalovirus retinitis with and without scleral buckling. Ophthalmology (1995) 1.01
Surgical management of macular pucker after retinal reattachment surgery. Am J Ophthalmol (1979) 1.00
Conjunctival pigmentation following pars plana vitrectomy. Retina (1987) 0.99
Ultrastructure of epiretinal membranes causing macular pucker after retinal re-attachment surgery. Trans Ophthalmol Soc U K (1979) 0.99
Ultrastructure of epiretinal membrane removed by pars plana vitreoretinal surgery. Am J Ophthalmol (1977) 0.99
Results and complications of 100 consecutive cases of pars plana vitrectomy. Am J Ophthalmol (1975) 0.99
Treatment of combined traction-rhegmatogenous retinal detachment in the morning glory syndrome. Retina (1985) 0.98
Reoperation after failed macular hole surgery. Retina (1996) 0.98
Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis. Ophthalmology (1993) 0.98
An unusual case of ocular involvement in primary systemic nonfamilial amyloidosis. Ophthalmology (1982) 0.97
Cystoid macular edema associated with topically applied epinephrine in aphakic eyes. Am J Ophthalmol (1975) 0.97
Persistent hyperplastic primary vitreous. Surgical treatment. Ophthalmology (1983) 0.96
Gravity-dependent distribution of retinal pigment epithelial cells dispersed into the vitreous cavity. Retina (1986) 0.96
Penetrating ocular injuries in young patients. Initial injuries and visual results. Retina (1984) 0.96
Ocular reticulum cell sarcoma. Clinicopathologic correlation of a case with multifocal lesions. Retina (1985) 0.96
Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel. Am J Ophthalmol (1999) 0.95
Effect of epsilon-aminocaproic acid on postvitrectomy hemorrhage. Arch Ophthalmol (1985) 0.94
Retreatment of full-thickness macular holes persisting after prior vitrectomy. A pilot study. Ophthalmology (1993) 0.93
Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.93
Congenital retinal arterial loops and vitreous hemorrhage. Am J Ophthalmol (1977) 0.93
Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology (1994) 0.93
Idiopathic nonvascularized epiretinal membranes in young patients: report of six cases. Ann Ophthalmol (1982) 0.93
Recovery of intraocular Toxocara canis by pars plana vitrectomy. Ophthalmology (1990) 0.93
The crystalline lens after vitrectomy for diabetic retinopathy. Ophthalmology (1984) 0.92
Long-term anatomic and functional results of vitrectomy for diabetic retinopathy. Am J Ophthalmol (1980) 0.92
Angioma-like mass in a patient with retrolental fibroplasia. Am J Ophthalmol (1980) 0.92
Evaluation of vitrectomy in penetrating ocular trauma. A case-control study. Arch Ophthalmol (1984) 0.92
Vitrectomy for nondiabetic vitreous hemorrhage. Am J Ophthalmol (1983) 0.92
Ultrastructural studies of vitreomacular traction syndrome. Am J Ophthalmol (1989) 0.91
Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy. Ophthalmology (1991) 0.91
Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells. Ophthalmology (1993) 0.91
The demonstration of angiogenic activity from ocular tissues. Preliminary report. Ophthalmology (1980) 0.91
Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.91
Vitrectomy techniques in retinal reattachment surgery. Ophthalmology (1979) 0.91